Sort
16,300 grants matching “fatty liver disease”
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression
$959,885M. Celeste Simon · University Of Pennsylvania · R35 · FY2021 · CA
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression
$959,881M. Celeste Simon · University Of Pennsylvania · R35 · FY2020 · CA
Project 1 - Changes in Gut Microbiome and related Metabolome Across Trajectory of Alzheimer's Disease
$959,860Rima F Kaddurah-Daouk · Duke University · U19 · FY2023 · AG
Hepatocyte Transplantation for Liver Based Metabolic Disease
$958,429Ira J. Fox · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DK
Hepatocyte Transplantation for Liver Based Metabolic Disease
$958,429Ira J. Fox · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · DK
Regulation Of Intracellular Iron Metabolism
$958,368Tracey A. Rouault · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD
Stem cells and aging
$956,383Toren Finkel · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Genetically Attenuated Malaria Attenuated Whole Parasite Sporozoite Vaccine
$956,277Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2012 · AI
Biobehavioral Studies of Obesity, Weight loss and Recidivism
$955,976Ranganath Muniyappa · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Non-invasive staging of Metastasis by Precision MRI
$954,220Jenny J Yang · Inlighta Biosciences, Llc · R44 · FY2022 · CA
University of Michigan Center for Gastrointestinal Research
$954,175Chung Owyang · University Of Michigan At Ann Arbor · P30 · FY2020 · DK
Phenotyping Genetic Disorders of Hepatic Lipid and Lipoprotein Metabolism in Cells, Mice, and Men
$953,882Henry N Ginsberg · Columbia University Health Sciences · R35 · FY2020 · HL
Phenotyping Genetic Disorders of Hepatic Lipid and Lipoprotein Metabolism in Cells, Mice, and Men
$953,882Henry N Ginsberg · Columbia University Health Sciences · R35 · FY2017 · HL
Phenotyping Genetic Disorders of Hepatic Lipid and Lipoprotein Metabolism in Cells, Mice, and Men
$953,882Henry N Ginsberg · Columbia University Health Sciences · R35 · FY2019 · HL
Phenotyping Genetic Disorders of Hepatic Lipid and Lipoprotein Metabolism in Cells, Mice, and Men
$953,882Henry N Ginsberg · Columbia University Health Sciences · R35 · FY2021 · HL
Phenotyping Genetic Disorders of Hepatic Lipid and Lipoprotein Metabolism in Cells, Mice, and Men
$953,882Henry N Ginsberg · Columbia University Health Sciences · R35 · FY2023 · HL
Phenotyping Genetic Disorders of Hepatic Lipid and Lipoprotein Metabolism in Cells, Mice, and Men
$953,882Henry N Ginsberg · Columbia University Health Sciences · R35 · FY2018 · HL
Phenotyping Genetic Disorders of Hepatic Lipid and Lipoprotein Metabolism in Cells, Mice, and Men
$953,882Henry N Ginsberg · Columbia University Health Sciences · R35 · FY2022 · HL
Epigenetic control during embryogenesis
$953,313Kathrin Muegge · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Subclinical Vascular Disease and Metabolic Abnormalities in MACS
$953,021Wendy S Post · Johns Hopkins University · R01 · FY2012 · HL
Molecular signatures for liver cancer diagnosis and treatment stratification
$952,089Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer
$950,923Mary Christine Playdon · University Of Utah · U01 · FY2023 · CA
Subclinical Vascular Disease and Metabolic Abnormalities in MACS
$950,109Wendy S Post · Johns Hopkins University · R01 · FY2010 · HL
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)
$948,453David W Crabb · Indiana University Indianapolis · U01 · FY2012 · AA
Accurate Point of Care Liver Disease Diagnostics, Phase II
$947,354Pablo J Prado · Livivos Inc. · R44 · FY2025 · DK